Feasibility of a Self-performed Urinary Test for the Follow-up on Medical Abortion (NCT02304835) | Clinical Trial Compass
CompletedNot Applicable
Feasibility of a Self-performed Urinary Test for the Follow-up on Medical Abortion
France322 participantsStarted 2013-05
Plain-language summary
This study was a national, longitudinal, prospective, observational survey, carried out in metropolitan France, with a sampling of 21 birth control centres.
The aim of this study was to assess, in real life conditions, the benefit of a urinary semi-quantitative test (hCG Duo 5-1000) in the follow-up of medical abortion by analysing the concordance between qualitative results from the urinary test and quantitative values from the beta-hCG blood measurement.
Who can participate
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult women (18 years old or more), pregnant the day of the medical examination and asking for medical abortion.
* Patients agreeing to participate in the study after have been informed orally by the physician and given the information sheet.
* Informed patients accepting the computer processing of their medical data and their right of access and correction.
Exclusion Criteria:
* Patients with more than 49 Days of Amenorrhea (DA) for private practice and 63 DA for hospital practice.
* Patients with contraindications to medical abortion.
* Patients with severe and progressive disease.
* Patients unable to complete a questionnaire.
* Patients refusing to participate in the study.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
concordance between qualitative results from the urinary test and quantitative values from the beta-hCG blood measurement.
Timeframe: At the follow-up at 2-3 weeks after inclusion